Murine cytomegalovirus protein pM92 Is a conserved regulator of viral late gene expression

Journal of Virology

Volumn 88, Issue 1, 2014, Pages 131-142

  Chapa, Travis J ^a   Perng, Yi Cheih ^a   French, Anthony R ^a   Yu, Dong ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MURINE CYTOMEGALOVIRUS PROTEIN PM92; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; FRAMESHIFT MUTATION; GENE EXPRESSION REGULATION; GENE LOCATION; GENE PRODUCT; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SEQUENCE ANALYSIS; VIROGENESIS; VIRUS INFECTION; VIRUS MUTANT; VIRUS REPLICATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CYTOMEGALOVIRUS; DNA PRIMERS; GENE EXPRESSION REGULATION, VIRAL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84890871832     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02684-13     Document Type: Article

References (65)

1. Mocarski ES, Shenk T, Pass RF. 2007. Cytomegaloviruses, p 2701-2772. In Knipe DM, Howley PM (ed), Fields virology5th ed, vol 2. Lippincott/ The Williams & Wilkins Co, Philadelphia, PA.
2. Steininger C. 2007. Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system. Clin. Microbiol. Infect. 13:953-963. http://dx.doi.org/10.1111/j.1469-0691.2007.01781.x.
3. Alford CA, Stagno S, Pass RF, Britt WJ. 1990. Congenital and perinatal cytomegalovirus infections. Rev. Infect. Dis. 12(Suppl 7):S745-S753
4. Grosse SD, Ross DS, Dollard SC. 2008. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J. Clin. Virol. 41:57-62. http://dx.doi.org/10.1016/j.jcv .2007.09.004
5. Streblow DN, Orloff SL, Nelson JA. 2007. Acceleration of allograft failure by cytomegalovirus. Curr. Opin. Immunol. 19:577-582. http://dx.doi.org /10.1016/j.coi.2007.07.012
6. Khan Z, Yaiw KC, Wilhelmi V, Lam H, Rahbar A, Stragliotto G, Soderberg-Naucler C. 1 October 2013. Human cytomegalovirus immediate- early proteins promote degradation of connexin 43 and disrupt gap junction communication: implications for a role in gliomagenesis. Carcinogenesis http://dx.doi.org/10.1093/carcin/bgt292
7. Skaletskaya A, Bartle LM, Chittenden T, McCormick AL, Mocarski ES, Goldmacher VS. 2001. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc. Natl. Acad. Sci. U. S. A. 98: 7829-7834. http://dx.doi.org/10.1073/pnas.141108798
8. Biron KK. 2006. Antiviral drugs for cytomegalovirus diseases. Antivir. Res. 71:154-163. http://dx.doi.org/10.1016/j.antiviral.2006.05.002
9. Fitzgerald NA, Papadimitriou JM, Shellam GR. 1990. Cytomegalovirusinduced pneumonitis and myocarditis in newborn mice. A model for perinatal human cytomegalovirus infection. Arch. Virol. 115:75-88
10. Rawlinson WD, Farrell HE, Barrell BG. 1996. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70:8833-8849
11. Reddehase MJ, Simon CO, Seckert CK, Lemmermann N, Grzimek NK. 2008. Murine model of cytomegalovirus latency and reactivation. Curr. Top. Microbiol. Immunol. 325:315-331. http://dx.doi.org/10.1007/978-3 -540-77349-8_18
12. Scalzo AA, Corbett AJ, Rawlinson WD, Scott GM, Degli-Esposti MA. 2007. The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection. Immunol. Cell Biol. 85:46-54. http://dx.doi .org/10.1038/sj.icb.7100013
13. Chapa TJ, Johnson LS, Affolter C, Valentine MC, Fehr AR, Yokoyama WM, Yu D. 2013. Murine cytomegalovirus protein pM79 is a key regulator for viral late transcription. J. Virol. 87:9135-9147. http://dx.doi.org/10.1128/JVI.00688-13
14. Arumugaswami V, Wu TT, Martinez-Guzman D, Jia Q, Deng H, Reyes N, Sun R. 2006. ORF18 is a transfactor that is essential for late gene transcription of a gammaherpesvirus. J. Virol. 80:9730-9740. http://dx .doi.org/10.1128/JVI.00246-06
15. Isomura H, Stinski MF, Murata T, Yamashita Y, Kanda T, Toyokuni S, Tsurumi T. 2011. The human cytomegalovirus gene products essential for late viral gene expression assemble into prereplication complexes before viral DNA replication. J. Virol. 85:6629-6644. http://dx.doi.org/10.1128/JVI.00384-11
16. Perng YC, Qian Z, Fehr AR, Xuan B, Yu D. 2011. The human cytomegalovirus gene UL79 is required for the accumulation of late viral transcripts. J. Virol. 85:4841-4852. http://dx.doi.org/10.1128/JVI.02344-10
17. Dunn W, Chou C, Li H, Hai R, Patterson D, Stolc V, Zhu H, Liu F. 2003. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U. S. A. 100:14223-14228. http://dx.doi.org/10.1073/pnas .2334032100
18. Song MJ, Hwang S, Wong WH, Wu TT, Lee S, Liao HI, Sun R. 2005. Identification of viral genes essential for replication of murine gammaherpesvirus 68 using signature-tagged mutagenesis. Proc. Natl. Acad. Sci. U. S. A. 102:3805-3810. http://dx.doi.org/10.1073/pnas.0404521102
19. Yu D, Silva MC, Shenk T. 2003. Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc. Natl. Acad. Sci. U. S. A. 100:12396-12401. http://dx.doi.org/10.1073/pnas.1635160100
20. 2) cytomegalovirus genes requires UL92 function that is conserved among beta- and gammaherpesviruses. J. Virol. 88:120-130. http://dx.doi.org/10.1128/JVI .02983-13
21. Kinsella TM, Nolan GP. 1996. Episomal vectors rapidly and stably pro- duce high-titer recombinant retrovirus. Hum. Gene Ther. 7:1405-1413. http://dx.doi.org/10.1089/hum.1996.7.12-1405
22. Baird GS, Zacharias DA, Tsien RY. 2000. Biochemistry, mutagenesis, and oligomerization of DsRed, a red fluorescent protein from coral. Proc. Natl. Acad. Sci. U. S. A. 97:11984-11989. http://dx.doi.org/10.1073/pnas .97.22.11984
23. Everett RD, Boutell C, McNair C, Grant L, Orr A. 2010. Comparison of the biological and biochemical activities of several members of the alphaherpesvirus ICP0 family of proteins. J. Virol. 84:3476-3487. http://dx.doi .org/10.1128/JVI.02544-09
24. Everett RD, Parsy ML, Orr A. 2009. Analysis of the functions of herpes simplex virus type 1 regulatory protein ICP0 that are critical for lytic infection and derepression of quiescent viral genomes. J. Virol. 83:4963- 4977. http://dx.doi.org/10.1128/JVI.02593-08
25. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG. 2005. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33:e36. http://dx.doi.org/10.1093/nar/gni035
26. Paredes AM, Yu D. 2012. Human cytomegalovirus: bacterial artificial chromosome (BAC) cloning and genetic manipulation. Curr. Protoc. Microbiol. Chapter. 14:Unit14E-14. http://dx.doi.org/10.1002/9780471729259 .mc14e04s24
27. Harvey DM, Levine AJ. 1991. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev. 5:2375-2385. http://dx.doi.org/10.1101/gad.5.12b.2375
28. Friedman HM, Koropchak C. 1978. Comparison of WI-38, MRC-5, and IMR-90 cell strains for isolation of viruses from clinical specimens. J. Clin. Microbiol. 7:368-371
29. Jacobs JP, Jones CM, Baille JP. 1970. Characteristics of a human diploid cell designated MRC-5. Nature 227:168-170. http://dx.doi.org/10.1038/227168a0
30. Everett RD, Orr A. 2009. Herpes simplex virus type 1 regulatory protein ICP0 AIDS infection in cells with a preinduced interferon response but does not impede interferon-induced gene induction. J. Virol. 83:4978- 4983. http://dx.doi.org/10.1128/JVI.02595-08
31. Yu D, Smith GA, Enquist LW, Shenk T. 2002. Construction of a selfexcisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene. J. Virol. 76:2316-2328. http://dx.doi.org/10.1128/jvi.76.5.2316-2328.2002
32. Wagner M, Jonjic S, Koszinowski UH, Messerle M. 1999. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J. Virol. 73:7056-7060
33. Busche A, Angulo A, Kay-Jackson P, Ghazal P, Messerle M. 2008. Phenotypes of major immediate-early gene mutants of mouse cytomegalovirus. Med. Microbiol. Immunol. 197:233-240. http://dx.doi.org/10 .1007/s00430-008-0076-3
34. Cardin RD, Abenes GB, Stoddart CA, Mocarski ES. 1995. Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice. Virology 209:236-241. http://dx.doi.org/10 .1006/viro.1995.1249
35. Manning WC, Mocarski ES. 1988. Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. Virology 167:477-484. http://dx.doi.org/10.1016/0042-6822(88)90110-9
36. Terhune S, Torigoi E, Moorman N, Silva M, Qian Z, Shenk T, Yu D. 2007. Human cytomegalovirus UL38 protein blocks apoptosis. J. Virol. 81:3109-3123. http://dx.doi.org/10.1128/JVI.02124-06
37. Xuan B, Qian Z, Torigoi E, Yu D. 2009. Human cytomegalovirus protein pUL38 induces ATF4 expression, inhibits persistent JNK phosphorylation, and suppresses endoplasmic reticulum stress-induced cell death. J. Virol. 83:3463-3474. http://dx.doi.org/10.1128/JVI.02307-08
38. Hay J, Brown SM, Jamieson AT, Rixon FJ, Moss H, Dargan DA, Subak-Sharpe JH. 1977. The effect of phosphonoacetic acid on herpesviruses. J. Antimicrob. Chemother. 3(Suppl A):63-70
39. Holland LE, Anderson KP, Shipman C, Jr., Wagner EK. 1980. Viral DNA synthesis is required for the efficient expression of specific herpes simplex virus type 1mRNAspecies. Virology 101:10-24. http://dx.doi.org/10.1016/0042-6822(80)90479-1
40. Huang ES, Huang CH, Huong SM, Selgrade M. 1976. Preferential inhibition of herpes-group viruses by phosphonoacetic acid: effect on virus DNA synthesis and virus-induced DNA polymerase activity. Yale J. Biol. Med. 49:93-99
41. Summers WC, Klein G. 1976. Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid. J. Virol. 18: 151-155
42. Amon W, Binne UK, Bryant H, Jenkins PJ, Karstegl CE, Farrell PJ. 2004. Lytic cycle gene regulation of Epstein-Barr virus. J. Virol. 78:13460- 13469. http://dx.doi.org/10.1128/JVI.78.24.13460-13469.2004
43. Chuluunbaatar U, Roller R, Feldman ME, Brown S, Shokat KM, Mohr I. 2010. Constitutive mTORC1 activation by a herpesvirus Akt surrogate stimulates mRNA translation and viral replication. Genes Dev. 24:2627- 2639. http://dx.doi.org/10.1101/gad.1978310
44. Deng H, Chu JT, Park NH, Sun R. 2004. Identification of cis sequences required for lytic DNA replication and packaging of murine gammaherpesvirus 68. J. Virol. 78:9123-9131. http://dx.doi.org/10.1128/JVI.78.17 .9123-9131.2004
45. Johnson PA, Everett RD. 1986. DNA replication is required for abundant expression of a plasmid-borne late US11 gene of herpes simplex virus type 1. Nucleic Acids Res. 14:3609-3625. http://dx.doi.org/10.1093/nar/14.9 .3609
46. Wade EJ, Spector DH. 1994. The human cytomegalovirus origin of DNA replication (oriLyt) is the critical cis-acting sequence regulating replication- dependent late induction of the viral 1.2-kilobase RNA promoter. J. Virol. 68:6567-6577
47. Bryant LA, Mixon P, Davidson M, Bannister AJ, Kouzarides T, Sinclair JH. 2000. The human cytomegalovirus 86-kilodalton major immediateearly protein interacts physically and functionally with histone acetyltransferase P/CAF. J. Virol. 74:7230-7237. http://dx.doi.org/10.1128/JVI .74.16.7230-7237.2000
48. Cuevas-Bennett C, Shenk T. 2008. Dynamic histone H3 acetylation and methylation at human cytomegalovirus promoters during replication in fibroblasts. J. Virol. 82:9525-9536. http://dx.doi.org/10.1128/JVI.00946-08
49. Groves IJ, Reeves MB, Sinclair JH. 2009. Lytic infection of permissive cells with human cytomegalovirus is regulated by an intrinsic 'preimmediate- early' repression of viral gene expression mediated by histone posttranslational modification. J. Gen. Virol. 90:2364-2374. http://dx.doi .org/10.1099/vir.0.012526-0
50. Kalamvoki M, Roizman B. 2011. The histone acetyltransferase CLOCK is an essential component of the herpes simplex virus 1 transcriptome that includes TFIID, ICP4, ICP27, and ICP22. J. Virol. 85:9472-9477. http://dx .doi.org/10.1128/JVI.00876-11
51. Liang Y, Vogel JL, Narayanan A, Peng H, Kristie TM. 2009. Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency. Nat. Med. 15:1312-1317. http://dx.doi .org/10.1038/nm.2051
52. Munch K, Buhler B, Messerle M, Koszinowski UH. 1991. The core histone-binding region of the murine cytomegalovirus 89K immediateearly protein. J. Gen. Virol. 72(Pt 8):1967-1974
53. Nevels M, Paulus C, Shenk T. 2004. Human cytomegalovirus immediate- early 1 protein facilitates viral replication by antagonizing histone deacetylation. Proc. Natl. Acad. Sci. U. S. A. 101:17234-17239. http://dx .doi.org/10.1073/pnas.0407933101
54. Cun W, Guo L, Zhang Y, Liu L, Wang L, Li J, Dong C, Wang J, Li Q. 2009. Transcriptional regulation of the Herpes Simplex Virus 1alpha-gene by the viral immediate-early protein ICP22 in association with VP16. Sci. China C Life Sci. 52:344-351. http://dx.doi.org/10.1007/s11427-009-0051-2
55. Herrera FJ, Triezenberg SJ. 2004. VP16-dependent association of chromatin- modifying coactivators and underrepresentation of histones at immediate- early gene promoters during herpes simplex virus infection. J. Virol. 78:9689-9696. http://dx.doi.org/10.1128/JVI.78.18.9689-9696 .2004
56. Berk AJ. 1999. Activation of RNA polymerase II transcription. Curr. Opin. Cell Biol. 11:330-335. http://dx.doi.org/10.1016/S0955-0674(99)80045-3
57. Lee TI, Young RA. 2000. Transcription of eukaryotic protein-coding genes. Annu. Rev. Genet. 34:77-137. http://dx.doi.org/10.1146/annurev .genet.34.1.77
58. Tamrakar S, Kapasi AJ, Spector DH. 2005. Human cytomegalovirus infection induces specific hyperphosphorylation of the carboxyl-terminal domain of the large subunit of RNA polymerase II that is associated with changes in the abundance, activity, and localization of cdk9 and cdk7. J. Virol. 79:15477- 15493. http://dx.doi.org/10.1128/JVI.79.24.15477-15493.2005
59. Weir JP. 2001. Regulation of herpes simplex virus gene expression. Gene 271:117-130. http://dx.doi.org/10.1016/S0378-1119(01)00512-1
60. Wu TT, Park T, Kim H, Tran T, Tong L, Martinez-Guzman D, Reyes N, Deng H, Sun R. 2009. ORF30 and ORF34 are essential for expression of late genes in murine gammaherpesvirus 68. J. Virol. 83:2265-2273. http://dx.doi.org/10.1128/JVI.01785-08
61. Lam Q, Smibert CA, Koop KE, Lavery C, Capone JP, Weinheimer SP, Smiley JR. 1996. Herpes simplex virus VP16 rescues viral mRNA from destruction by the virion host shutoff function. EMBO J. 15:2575-2581
62. Sciortino MT, Taddeo B, Giuffre-Cuculletto M, Medici MA, Mastino A, Roizman B. 2007. Replication-competent herpes simplex virus 1 isolates selected from cells transfected with a bacterial artificial chromosomeDNA lacking only the UL49 gene vary with respect to the defect in the UL41 gene encoding host shutoff RNase. J. Virol. 81:10924-10932. http://dx.doi.org/10.1128/JVI.01239-07
63. Shu M, Taddeo B, Zhang W, Roizman B. 2013. Selective degradation of mRNAs by the HSV host shutoff RNase is regulated by the UL47 tegument protein. Proc. Natl. Acad. Sci. U. S. A. 110:E1669-1675. http://dx.doi.org/10.1073/pnas.1305475110
64. Taddeo B, Zhang W, Roizman B. 2010. Role of herpes simplex virus ICP27 in the degradation of mRNA by virion host shutoff RNase. J. Virol. 84:10182-10190. http://dx.doi.org/10.1128/JVI.00975-10
65. Stinski MF, Isomura H. 2008. Role of the cytomegalovirus major immediateearly enhancer in acute infection and reactivation from latency. Med. Microbiol. Immunol. 197:223-231. http://dx.doi.org/10.1007/s00430-007-0069-7